Aslani, Rina H.
HRN: 13-46-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2022
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
12/07/2022
12/09/2022
PO
5 Ml
BID
Ascariasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes